2026 IPO bonanza! Over 90% of new stocks rose on their debut

On May 6, 2026, $COFOE MEDICAL (01187.HK)$ officially listed on the Main Board of the Hong Kong Stock Exchange, becomingthe fourth 'A+H' share listed company in Hunan Province.In this IPO, Futu acted as the overall coordinator (OC), joint global coordinators (JGC), joint bookrunners (JBR), and joint lead managers (JLM),deeply participating in the entire issuance process.
In the meantime,Futu was also the financial public relations partner for this IPO,leveraging its deep expertise in capital markets and mature service system to empower this IPO.
Cofo Medical is a leading domestic home medical device company in China. Relying on its industry-leading portfolio of home medical products, which includes over 200 product types and tens of thousands of product specifications, Cofo Medical can effectively meet the needs of family members across different age groups. According to Frost & Sullivan, based on domestic revenue in 2024, the company ranks second among all home medical device companies in China with a market share of 2.1%.

For the fiscal years ended December 31, 2023, 2024, and 2025, Cofo Medical's revenue reached RMB 2,853.7 million, RMB 2,982.9 million, and RMB 3,387.5 million, respectively. The company’s gross profit in 2023, 2024, and 2025 was RMB 1,172.6 million, RMB 1,508.7 million, and RMB 1,751.6 million, respectively. The net profit for the same period from 2023 to 2025 was RMB 252.9 million, RMB 312.3 million, and RMB 370.3 million, respectively.

In terms of fundraising purposes, Koifu Healthcare expects net proceeds from the global offering to amount to approximately HKD 1.007 billion (based on an offer price of HKD 39.33). According to the prospectus, Koifu Healthcare intends to allocate the proceeds from the global offering for the following purposes.
Approximately 30% will be used for global expansion; around 30% will be allocated for the company's ongoing product research and development and technological innovation, including its artificial intelligence and Internet of Things applications; about 20% will be directed toward expanding the company’s domestic sales channels and distribution networks; roughly 10% will be used for brand promotion and marketing activities; and approximately 10% will be reserved for working capital and general corporate purposes.
--------------------------------------------------
As a leading digital financial technology company, Futu, supported by an investor ecosystem of over 29.18 million and a comprehensive corporate service system, is able to provide companies with end-to-end services throughout the pre-IPO, IPO, and post-IPO phases. These include a one-stop ESOP option management solution, Hong Kong and US stock IPO distribution, investor relations (IR) and public relations (PR), financial public relations services, international placement, secondary trading services, and other core services.
As of Q4 2025, more than half of the top ten companies in terms of Hong Kong IPO fundraising amounts have collaborated with Futu. Nearly half of the Hong Kong IPO projects in Q4 were in cooperation with Futu. The total subscription amount for Hong Kong IPOs on the Futu platform reached 3.5 trillion Hong Kong dollars in Q4, firmly ranking first in the market. Futu’s capabilities in US IPOs have attracted attention, as all retail clients who subscribed to popular new stocks such as Bullish, Figure, and Gemini were successfully allocated shares.
As of Q4 2025, Futu's corporate services have reached 1,161 clients, providing IPO distribution and IR services to 600 enterprises. It has assisted 387 companies, including Meituan, Kuaishou, Xiaomi, Baidu, KE Holdings, JD Health, and Bilibili, in successfully listing in Hong Kong and the United States. Futu has cumulatively signed contracts with 830 ESOP clients, and a total of 1,300 listed companies are now hosted on the Futu platform.
In the future, Futu will fully leverage its resources and market influence to provide more professional and efficient services to a larger customer base!
*Securities-related businesses such as IPO distribution are provided by licensed subsidiaries under Futu.
*Data source: Market cap as of the first day of listing
*Data source: Futu's Q4 2025 earnings report
Risk Disclaimer: The above content only represents the author's view. It does not represent any position or investment advice of Futu. Futu makes no representation or warranty.Read more
Comment (1)
to post a comment
2
